The Face of Diabetes: Honoring Courage and Community, June 14th

Celebrating strength and resilience in the Rio Grande Valley

Translate to Spanish or other 102 languages!

The Rio Grande Valley Diabetes Association (RGVDA) will host “The Face of Diabetes,” a special event celebrating the determination and resilience of individuals with diabetes. Scheduled for Saturday, June 14th, from 11:00 AM to 1:00 PM at the Radisson McAllen Hotel Airport, the event aims to recognize local community members who continue to face the challenges of diabetes with strength, dignity, and hop. Courtesy image. Bgd for illustration purposes
The Rio Grande Valley Diabetes Association (RGVDA) will host “The Face of Diabetes,” a special event celebrating the determination and resilience of individuals with diabetes. Scheduled for Saturday, June 14th, from 11:00 AM to 1:00 PM at the Radisson McAllen Hotel Airport, the event aims to recognize local community members who continue to face the challenges of diabetes with strength, dignity, and hop. Courtesy image. Bgd for illustration purposes
- Advertisement -

Mega Doctor News

The Rio Grande Valley Diabetes Association (RGVDA) will host “The Face of Diabetes,” a special event celebrating the determination and resilience of individuals with diabetes. Scheduled for Saturday, June 14th, from 11:00 AM to 1:00 PM at the Radisson McAllen Hotel Airport, the event aims to recognize local community members who continue to face the challenges of diabetes with strength, dignity, and hope.

This annual celebration will spotlight inspiring individuals whose stories exemplify perseverance and advocacy in the face of a chronic illness. Honorees include Amir Elsayed, Dr. Ofelia Averack, Judge Hector Bustos, Suzy Yoon Lee, Diana Stansberry, Rosie Aguirre, Armando Salinas, Visha Daniec, Natalie Buentello, Roy Cantu, Melba Gutierrez, Dr. Rosalva Dehoyos, Mike Robledo, Candace Rodriguez, Edward Polaco, and Rick Aguirre.

- Advertisement -
Courtesy image

In addition to the awards ceremony, the event will feature a fashion show with models from the Debi Lou Modeling Academy. Macy’s will provide the latest apparel for the runway, adding a stylish flair to the meaningful occasion.

The RGVDA, founded in 2007 and based in McAllen, Texas, is a nonprofit organization dedicated to preventing diabetes and reducing its complications through education, early detection, and community outreach. All funds raised are used locally to support diabetes management programs, meal planning education, and support groups for children and adults.

As of 2025, the organization is led by President and Founder Dr. Monzer H. Yazji, MD, with Dr. Luis Reyes serving as Chairman. The board of directors includes Amir Elsayed, Victor Daniec, and Iliana Guerra Martinez, RD, LD, CDE.

For ticket details or more information, the public should contact the RGVDA at (956) 318-1900 or visit their office at 3200 N. 23rd St., Suite A, McAllen, TX 78501. Additional resources are available at rgvda.org.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Recertified for Advanced Hip & Knee Replacements

DHR Health has once again earned The Joint Commission's Advanced Certification in Total Hip and Total Knee Replacement, reaffirming its commitment to providing high-quality, patient-centered orthopedic care to the Rio Grande Valley.

STHS Named to Newsweek’s America’s Greatest Midsize Workplaces for Women

The American workforce is more diverse than ever, with women helping lead that transformation. 

Dysfunctional, Not Missing, Immune Cells Explain Skin Cancer Risk in Immunosuppressed Patients

Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, but those cells – known as macrophages – have lost the ability to communicate effectively.

New Study Reveals Real-World Safety Findings for Latest Alzheimer’s Treatment

As new Alzheimer’s drugs move from clinical trials into everyday care, families are asking whether these treatments are safe, how long patients can stay on them, and whether they truly slow the disease outside tightly controlled studies.
- Advertisement -